RELATIONSHIP BETWEEN C-ERBB-2 IMMUNOREACTIVITY AND THYMIDINE LABELING INDEX IN BREAST-CARCINOMA INSITU

被引:48
|
作者
BARNES, DM
MEYER, JS
GONZALEZ, JG
GULLICK, WJ
MILLIS, RR
机构
[1] ST LUKES HOSP,CHESTERFIELD,MO
[2] JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110
[3] WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110
[4] HAMMERSMITH HOSP,IMPERIAL CANC RES FUND,MOLEC ONCOL GRP,LONDON W12 0HS,ENGLAND
关键词
C-ERBB-2; IMMUNOHISTOCHEMISTRY; THYMIDINE LABELING INDEX; BREAST CARCINOMA INSITU;
D O I
10.1007/BF01975438
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between the presence of the c-erbB-2 protein, demonstrated immunohistochemically with antibody 21N, and thymidine labelling index (TLI) has been studied in the in situ component of 70 cases of carcinoma of the breast. A significant association was found between high TLI and positive staining. Twenty of the 70 cases stained (29%) and of those that were stained 75% had a high TLI; 43% of those with a high TLI stained positively but only 14% of those with a low TLI stained positively. Strong correlations were seen between nuclear size and histological pattern and both 21N staining and TLI. The majority of carcinomas of comedo pattern with large nuclei were 21N positive and had a high TLI, whilst those with small nuclei and a predominantly cribriform/micropapillary appearance did not stain and had a low TLI. In tumours of mixed histological pattern there was less concordance between staining and TLI. The significance of these findings in relation to the biological behaviour of these tumours and their clinical management is discussed.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [31] The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer
    Gürel, S
    Dolar, E
    Yerci, Ö
    Samli, B
    Öztürk, H
    Nak, SG
    Gülten, M
    Memik, F
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1999, 27 (02) : 74 - 78
  • [32] CORRELATION BETWEEN C-erbB-2 WITH GASTRIC MUCOSAL ATYPICAL HYPERPLASIA AND GASTRIC CARCINOMA
    Song, B.
    Yu, J.
    Wu, T. S.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2015, 29 (02) : 471 - 477
  • [33] DETERMINATION OF AMPLIFICATION LEVEL OF THE C-ERBB-2 PROTOONCOGENE IN HUMAN BREAST CARCINOMAS - A COMPARATIVE-STUDY BETWEEN NONRADIOACTIVE AND RADIOACTIVE LABELING
    EDORH, A
    PARACHE, RM
    NSOSSANI, B
    BOTTIN, MC
    MERLIN, JL
    COLOSETTI, P
    GUILLEMIN, F
    LEFAOU, A
    RIHN, B
    CELLULAR AND MOLECULAR BIOLOGY, 1995, 41 (07) : 967 - 973
  • [34] C-ERBB-2 EXPRESSION IN BREAST-CANCER DETECTED BY IMMUNOBLOTTING AND IMMUNOHISTOCHEMISTRY
    KERNS, BJM
    PENCE, JC
    HUPER, G
    KINNEY, RB
    IGLEHART, JD
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (12) : 1823 - 1830
  • [35] IMMUNOHISTOCHEMICAL STUDY ON THE EXPRESSION OF C-ERBB-2 ONCOPROTEIN IN BREAST-CANCER
    HORIGUCHI, J
    IINO, Y
    TAKEI, H
    YOKOE, T
    ISHIDA, T
    MORISHITA, Y
    ONCOLOGY, 1994, 51 (01) : 47 - 51
  • [36] EXPRESSION OF C-ERBB-2 GENE IN HUMAN HEAD AND NECK-CARCINOMA
    CRAVEN, JM
    PAVELIC, ZP
    STAMBROOK, PJ
    PAVELIC, L
    GAPANY, M
    KELLEY, DJ
    GAPANY, S
    GLUCKMAN, JL
    ANTICANCER RESEARCH, 1992, 12 (6B) : 2273 - 2276
  • [37] c-myc, c-erbB-1 and c-erbB-2 expressions in urothelial carcinoma
    Onodera, T
    Hashimoto, Y
    Yagihashi, S
    PATHOLOGY INTERNATIONAL, 1997, 47 (04) : 209 - 216
  • [38] Amplification of c-erbB-2 gene in female breast cancer
    Zadrozny, M
    Smolarz, B
    Romanowicz-Makowska, H
    Kozlowska, E
    Kulig, A
    EXPERIMENTAL ONCOLOGY, 2002, 24 (03): : 198 - 202
  • [39] The role of c-erbB-2 as a predictive factor in breast cancer
    Yamauchi H.
    Stearns V.
    Hayes D.F.
    Breast Cancer, 2001, 8 (3) : 171 - 183
  • [40] C-ERBB-2 PROTEIN AND NEUROENDOCRINE EXPRESSION IN BREAST CARCINOMAS
    NESLAND, JM
    OTTESTAD, L
    HEIKILLA, R
    HOLM, R
    TVEIT, K
    BORRESEN, AL
    ANTICANCER RESEARCH, 1991, 11 (01) : 161 - 167